1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Orthopedics Market Trends
  5. > North America Hip Reconstruction Market Outlook to 2021

North America Hip Reconstruction Market Outlook to 2021

  • August 2015
  • -
  • Global Data
  • -
  • 168 pages

North America Hip Reconstruction Market Outlook to 2021

Summary

GlobalData’s new report, "North America Hip Reconstruction Market Outlook to 2021", provides key market data on the North America Hip Reconstruction market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Primary Hip Replacement, Revision Hip Replacement, Partial Hip Replacement and Hip Resurfacing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country/region, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Hip Reconstruction market segments - Primary Hip Replacement, Revision Hip Replacement, Partial Hip Replacement and Hip Resurfacing.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Hip Reconstruction market.
- Global corporate-level profiles of key companies operating within the North America Hip Reconstruction market.
- Key players covered include Zimmer Holdings, Inc., Stryker Corporation, DePuy Companies, Smith & Nephew Plc, Biomet, Inc. and Wright Medical Group, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

North America Hip Reconstruction Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Hip Reconstruction Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 11
3 Hip Reconstruction Market, North America 13
3.1 Hip Reconstruction Market, North America, Revenue ($m), 2007-2021 13
3.2 Hip Reconstruction Market, North America, Category Comparison by Revenue ($m), 2007-2021 15
3.3 Hip Reconstruction Market, North America, Revenue ($m), 2007-2014 16
3.4 Hip Reconstruction Market, North America, Revenue ($m), 2014-2021 18
3.5 Hip Reconstruction Market, North America, Volume (Units), 2007-2021 20
3.6 Hip Reconstruction Market, North America, Volume (Units), 2007-2014 22
3.7 Hip Reconstruction Market, North America, Volume (Units), 2014-2021 24
3.8 Hip Reconstruction Market, North America, Company Share by Revenue ($m), 2014 26
4 Hip Reconstruction Market, Canada 28
4.1 Hip Reconstruction Market, Canada, Revenue ($m), 2007-2014' 28
4.2 Hip Reconstruction Market, Canada, Revenue ($m), 2014-2021 30
4.2.1 Primary Hip Replacement Market, Canada, Revenue ($m), by Segment, 2007-2014 32
4.2.2 Primary Hip Replacement Market, Canada, Revenue ($m), by Segment, 2014-2021 34
4.3 Hip Reconstruction Market, Canada, Volume (Units), 2007-2014 36
4.4 Hip Reconstruction Market, Canada, Volume (Units), 2014-2021 38
4.4.1 Primary Hip Replacement Market, Canada, Volume (Units), by Segment, 2007-2014 40
4.4.2 Primary Hip Replacement Market, Canada, Volume (Units), by Segment, 2014-2021 42
4.5 Hip Reconstruction Market, Canada, Average Price ($), 2007-2021 44
4.6 Hip Reconstruction Market, Canada, Distribution Share by Revenue ($m), 2013-2014 46
4.7 Hip Reconstruction Market, Canada, Company Share by Revenue ($m), 2014 47
5 Hip Reconstruction Market, Mexico 49
5.1 Hip Reconstruction Market, Mexico, Revenue ($m), 2007-2014 49
5.2 Hip Reconstruction Market, Mexico, Revenue ($m), 2014-2021 51
5.2.1 Primary Hip Replacement Market, Mexico, Revenue ($m), by Segment, 2007-2014 53
5.2.2 Primary Hip Replacement Market, Mexico, Revenue ($m), by Segment, 2014-2021 55
5.3 Hip Reconstruction Market, Mexico, Volume (Units), 2007-2014 57
5.4 Hip Reconstruction Market, Mexico, Volume (Units), 2014-2021 59
5.4.1 Primary Hip Replacement Market, Mexico, Volume (Units), by Segment, 2007-2014 61
5.4.2 Primary Hip Replacement Market, Mexico, Volume (Units), by Segment, 2014-2021 63
5.5 Hip Reconstruction Market, Mexico, Average Price ($), 2007-2021 65
5.6 Hip Reconstruction Market, Mexico, Distribution Share by Revenue ($m), 2013-2014 67
5.7 Hip Reconstruction Market, Mexico, Company Share by Revenue ($m), 2014 68
6 Hip Reconstruction Market, United States 70
6.1 Hip Reconstruction Market, United States, Revenue ($m), 2007-2014 70
6.2 Hip Reconstruction Market, United States, Revenue ($m), 2014-2021 72
6.2.1 Partial Hip Replacement Market, United States, Revenue ($m), by Segment, 2007-2014 74
6.2.2 Primary Hip Replacement Market, United States, Revenue ($m), by Segment, 2007-2014 76
6.2.3 Partial Hip Replacement Market, United States, Revenue ($m), by Segment, 2014-2021 78
6.2.4 Primary Hip Replacement Market, United States, Revenue ($m), by Segment, 2014-2021 80
6.3 Hip Reconstruction Market, United States, Volume (Units), 2007-2014 82
6.4 Hip Reconstruction Market, United States, Volume (Units), 2014-2021 84
6.4.1 Partial Hip Replacement Market, United States, Volume (Units), by Segment, 2007-2014 86
6.4.2 Primary Hip Replacement Market, United States, Volume (Units), by Segment, 2007-2014 88
6.4.3 Partial Hip Replacement Market, United States, Volume (Units), by Segment, 2014-2021 90
6.4.4 Primary Hip Replacement Market, United States, Volume (Units), by Segment, 2014-2021 92
6.5 Hip Reconstruction Market, United States, Average Price ($), 2007-2021 94
6.6 Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), 2013-2014 96
6.7 Hip Reconstruction Market, United States, Company Share by Revenue ($m), 2014 97
7 Overview of Key Companies in North America Hip Reconstruction Market 99
7.1 DePuy Companies 99
7.1.1 Company Overview 99
7.2 Stryker Corporation 99
7.2.1 Company Overview 99
7.3 Zimmer Biomet Holdings, Inc. 99
7.3.1 Company Overview 99
7.4 Smith and Nephew Plc 100
7.4.1 Company Overview 100
7.5 Biomet, Inc. (Inactive) 100
7.5.1 Company Overview 100
7.6 MicroPort Scientific Corporation 101
7.6.1 Company Overview 101
7.7 DJO Finance LLC 101
7.7.1 Company Overview 101
8 Hip Reconstruction Market Pipeline Products 102
9 Recent Developments 104
9.1 Corporate Communications 104
9.1.1 Feb 17, 2015: Memorial Health Increases CT Exam Safety and Efficacy with Toshiba's Aquilion ONE 104
9.1.2 Dec 12, 2014: Zimmer Holdings Names Michael Farrell to Board of Directors 104
9.1.3 Dec 04, 2014: Brainsway Receives CE Approval for Deep TMS System - OCD 105
9.1.4 Oct 13, 2014: Amedica Announces Unexpected Passing of Former Chairman of the Board Max E. Link, Ph.D. 105
9.1.5 Oct 07, 2014: Amedica Appoints Eric A. Stookey to the Board of Directors 106
9.1.6 Sep 30, 2014: Amedica Appoints New President and Chief Executive Officer 106
9.1.7 Sep 29, 2014: AHS Leader Wright Lassiter New President of Henry Ford Health System 107
9.1.8 Sep 29, 2014: Amedica Appoints New Vice President of Business Development 108
9.1.9 Sep 15, 2014: Wright Medical Group, Inc. Appoints Kevin D. Cordell as President, U.S. Extremities 108
9.2 Financial Announcements 109
9.2.1 Jul 30, 2015: Zimmer Biomet Reports Second Quarter 2015 Financial Results 109
9.2.2 Jul 28, 2015: Exactech Q2 2015 Revenue $61.5 Million. Net Income $3.7 Million. Diluted EPS $0.26. 109
9.2.3 Jul 27, 2015: Amedica Announces Preliminary Q2 2015 Financial Results and Update on Recent FDA Response 111
9.2.4 Jul 23, 2015: Stryker Reports Second Quarter 2015 Results 111
9.2.5 May 18, 2015: Intra-Cellular Therapies Announces Further Analyses of the Phase 2 Clinical Trial of ITI-007 in Schizophrenia at the 168th Annual Meeting of the American Psychiatric Association 112
9.2.6 May 07, 2015: Amedica Reports First Quarter 2015 Financial Results 115
9.2.7 Apr 30, 2015: Zimmer Holdings Reports First Quarter 2015 Financial Results 117
9.2.8 Apr 28, 2015: Exactech Q1 Revenue $61.4 Million. Net Income Down 2% to $4.1 Million. Diluted EPS $0.29 vs. $0.30. 117
9.2.9 Apr 21, 2015: Stryker Reports First Quarter 2015 Results 118
9.2.10 Apr 09, 2015: Biomet Announces Third Quarter of Fiscal Year 2015 Financial Results 119
9.2.11 Mar 12, 2015: Cynata Therapeutics Commences Further Stage of Stem Cell Manufacturing Program 120
9.2.12 Mar 05, 2015: Amedica Reports Fourth Quarter and Full Year 2014 Financial Results 121
9.2.13 Feb 24, 2015: Zimmer Holdings Announces Quarterly Dividend for First Quarter of 2015 122
9.2.14 Feb 17, 2015: Exactech 2014 Revenue Up 5% to $248.4 Million, Net Income Up 7% to $16.5 Million, EPS $1.18 122
9.2.15 Feb 11, 2015: Stryker Declares a 13% Increase in Quarterly Dividend 123
9.2.16 Jan 29, 2015: Zimmer Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 123
9.2.17 Jan 27, 2015: Stryker Reports 2014 Results 124
9.2.18 Jan 13, 2015: Stryker Provides 2014 Preliminary Results and Updates 2015 Foreign Exchange Outlook 125
9.2.19 Jan 06, 2015: Biomet Announces Second Quarter of Fiscal Year 2015 Financial Results 126
9.2.20 Dec 23, 2014: Repro Med Systems Announces Strong Results for Third Quarter Ended November 30, 2014 127
9.2.21 Dec 18, 2014: Amedica Announces Preliminary Q4 and FY 2014 Financial Results and Update on CASCADE Clinical Study 128
9.2.22 Dec 15, 2014: Zimmer Holdings Announces Quarterly Dividend for Fourth Quarter of 2014 128
9.2.23 Dec 04, 2014: Ra Pharmaceuticals Announces Presentation of Data Supporting Clinical Development of Novel Complement C5 Inhibitor at 2014 ASH Annual Meeting 128
9.2.24 Dec 03, 2014: Stryker Declares a 13% Increase in Quarterly Dividend 130
9.2.25 Nov 06, 2014: Amedica Reports Third Quarter 2014 Financial Results 130
9.2.26 Nov 06, 2014: Tornier Reports Third Quarter 2014 Results 131
9.2.27 Nov 05, 2014: Wright Medical Group, Inc. Reports 2014 Third Quarter Financial Results and Updated Guidance 132
9.2.28 Oct 23, 2014: Pfizer Wins SUTENT Patent Case In Delaware District Court 134
9.2.29 Oct 23, 2014: Zimmer Holdings Reports Third Quarter 2014 Financial Results 135
9.2.30 Oct 21, 2014: Exactech Q3 Revenue Up 4% to $57.9 Million; Net Income Down 6% to $3.0 Million Due to Currency Losses; Q3 Diluted EPS $0.21 vs. $0.23 136
9.2.31 Oct 16, 2014: Stryker Reports Third Quarter 2014 Results and 2014 Outlook 137
9.2.32 Oct 14, 2014: MOLOGEN AG presents EnanDIM: A new generation of immunomodulators 139
9.2.33 Oct 09, 2014: Biomet Announces First Quarter of Fiscal Year 2015 Financial Results 141
9.2.34 Aug 07, 2014: Amedica Reports Second Quarter 2014 Financial Results 142
9.2.35 Aug 05, 2014: Wright Medical Group, Inc. Reports 2014 Second Quarter Financial Results 143
9.3 Government and Public Interest 145
9.3.1 Jul 09, 2015: CMS proposes major initiative for hip and knee replacements 145
9.4 Legal And Regulatory 146
9.4.1 Jun 13, 2015: Wright Medical Technology Loses In Profemur R Hip Device Lawsuit 146
9.4.2 Dec 15, 2014: FDA Issues Warning Letter To Signal Medical 146
9.4.3 Oct 31, 2014: Biomet to Pay Over $6 Million to Resolve Whistleblower Claims That It Paid Kickbacks to Doctors 146
9.4.4 Oct 29, 2014: Biomet Companies to Pay Over $6 Million to Resolve False Claims Act Allegations Concerning Bone Growth Stimulators 147
9.5 Other Significant Developments 148
9.5.1 Mar 25, 2015: Mental Health Disorders Complicate Standards Readmissions 148
9.5.2 Mar 23, 2015: Federally Funded Project Establishes First National Database of Comprehensive Benchmarks for Total Hip and Knee Joint Replacement 149
9.5.3 Feb 10, 2015: Drug targeting Ebola virus protein VP24 shows promise in monkeys 151
9.5.4 Dec 23, 2014: Micron Products Announces Exclusive Agreement With New Era Orthopaedics 152
9.5.5 Nov 19, 2014: Oxford Performance Materials Receives Prestigious National Institutes Of Health Grant To Improve Treatment Of Infections Related To Artificial Hips, Knees And Other Implanted Devices 152
9.5.6 Aug 26, 2014: Zimmer Holdings Announces Quarterly Dividend for Third Quarter of 2014 153
9.5.7 Aug 21, 2014: Stryker Declares a $0.305 Quarterly Dividend July 2014 153
9.6 Product News 153
9.6.1 Aug 22, 2014: Advanced Hip Replacement Solutions from Zimmer Offer Once In A Lifetime Technology 153
9.7 Strategy And Business Planning 154
9.7.1 Apr 15, 2015: Motif Gains FDA Agreement To Enter Phase 3 Clinical Development With Iclaprim 154
9.7.2 Jan 20, 2015: InterMed Resources and Amedica Announce Agreement With HealthTrust 155
9.7.3 Jan 16, 2015: ZIMMER expands Irish Manufacturing presence 155
9.7.4 Jan 12, 2015: Amedica Announces Steps to Simplify Organization and Align Financial Objectives 156
9.7.5 Oct 30, 2014: Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing Of The Biomet Transaction 157
9.7.6 Sep 23, 2014: Stryker plans to construct new Innovation Centre in Cork 159
10 Appendix 160
10.1 Research Methodology 161
10.1.1 Coverage 161
10.1.2 Secondary Research 161
10.1.3 Primary Research 162
10.1.4 Market Modeling and Forecasting 163
10.1.5 Company Share Analysis 166
10.1.6 Distribution Share Analysis 167
10.2 Expert Panel 168
10.3 GlobalData Consulting 168
10.4 Contact Us 168
10.5 Disclaimer 168

1.1 List of Tables
Table 1: Hip Reconstruction Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 14
Table 2: Hip Reconstruction Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021 15
Table 3: Hip Reconstruction Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 17
Table 4: Hip Reconstruction Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 19
Table 5: Hip Reconstruction Market, North America, Volume (Units), 2007-2021 21
Table 6: Hip Reconstruction Market, North America, Volume (Units), Historic, 2007-2014 23
Table 7: Hip Reconstruction Market, North America, Volume (Units), Forecast, 2014-2021 25
Table 8: Hip Reconstruction Market, North America, Company Share by Revenue ($m), USD Constant, 2014 27
Table 9: Hip Reconstruction Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 29
Table 10: Hip Reconstruction Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Table 11: Primary Hip Replacement Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 33
Table 12: Primary Hip Replacement Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 35
Table 13: Hip Reconstruction Market, Canada, Volume (Units), Historic, 2007-2014 37
Table 14: Hip Reconstruction Market, Canada, Volume (Units), Forecast, 2014-2021 39
Table 15: Primary Hip Replacement Market, Canada, Volume (Units), Historic, 2007-2014 41
Table 16: Primary Hip Replacement Market, Canada, Volume (Units), Forecast, 2014-2021 43
Table 17: Hip Reconstruction Market, Canada, Average Price ($), Historic, 2007-2014 44
Table 18: Hip Reconstruction Market, Canada, Average Price ($), Forecast, 2014-2021 45
Table 19: Hip Reconstruction Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 46
Table 20: Hip Reconstruction Market, Canada, Company Share by Revenue ($m), USD Constant, 2013-2014 48
Table 21: Hip Reconstruction Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 50
Table 22: Hip Reconstruction Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 52
Table 23: Primary Hip Replacement Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 54
Table 24: Primary Hip Replacement Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Table 25: Hip Reconstruction Market, Mexico, Volume (Units), Historic, 2007-2014 58
Table 26: Hip Reconstruction Market, Mexico, Volume (Units), Forecast, 2014-2021 60
Table 27: Primary Hip Replacement Market, Mexico, Volume (Units), Historic, 2007-2014 62
Table 28: Primary Hip Replacement Market, Mexico, Volume (Units), Forecast, 2014-2021 64
Table 29: Hip Reconstruction Market, Mexico, Average Price ($), Historic, 2007-2014 65
Table 30: Hip Reconstruction Market, Mexico, Average Price ($), Forecast, 2014-2021 66
Table 31: Hip Reconstruction Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014 67
Table 32: Hip Reconstruction Market, Mexico, Company Share by Revenue ($m), USD Constant, 2013-2014 69
Table 33: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 71
Table 34: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 73
Table 35: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 75
Table 36: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 77
Table 37: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 79
Table 38: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 81
Table 39: Hip Reconstruction Market, United States, Volume (Units), Historic, 2007-2014 83
Table 40: Hip Reconstruction Market, United States, Volume (Units), Forecast, 2014-2021 85
Table 41: Partial Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014 87
Table 42: Primary Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014 89
Table 43: Partial Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021 91
Table 44: Primary Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021 93
Table 45: Hip Reconstruction Market, United States, Average Price ($), Historic, 2007-2014 94
Table 46: Hip Reconstruction Market, United States, Average Price ($), Forecast, 2014-2021 95
Table 47: Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 96
Table 48: Hip Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2014 98
Table 49: Hip Reconstruction Market Pipeline Products 102
Table 50: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 163

1.2 List of Figures
Figure 1: Hip Reconstruction Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 13
Figure 2: Hip Reconstruction Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021 15
Figure 3: Hip Reconstruction Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 16
Figure 4: Hip Reconstruction Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 18
Figure 5: Hip Reconstruction Market, North America, Volume (Units), 2007-2021 20
Figure 6: Hip Reconstruction Market, North America, Volume (Units), Historic, 2007-2014 22
Figure 7: Hip Reconstruction Market, North America, Volume (Units), Forecast, 2014-2021 24
Figure 8: Hip Reconstruction Market, North America, Company Share (%) 2014 26
Figure 9: Hip Reconstruction Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 28
Figure 10: Hip Reconstruction Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Figure 11: Primary Hip Replacement Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 32
Figure 12: Primary Hip Replacement Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 34
Figure 13: Hip Reconstruction Market, Canada, Volume (Units), Historic, 2007-2014 36
Figure 14: Hip Reconstruction Market, Canada, Volume (Units), Forecast, 2014-2021 38
Figure 15: Primary Hip Replacement Market, Canada, Volume (Units), Historic, 2007-2014 40
Figure 16: Primary Hip Replacement Market, Canada, Volume (Units), Forecast, 2014-2021 42
Figure 17: Hip Reconstruction Market, Canada, Company Share (%) 2014 47
Figure 18: Hip Reconstruction Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 49
Figure 19: Hip Reconstruction Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 51
Figure 20: Primary Hip Replacement Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 53
Figure 21: Primary Hip Replacement Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Figure 22: Hip Reconstruction Market, Mexico, Volume (Units), Historic, 2007-2014 57
Figure 23: Hip Reconstruction Market, Mexico, Volume (Units), Forecast, 2014-2021 59
Figure 24: Primary Hip Replacement Market, Mexico, Volume (Units), Historic, 2007-2014 61
Figure 25: Primary Hip Replacement Market, Mexico, Volume (Units), Forecast, 2014-2021 63
Figure 26: Hip Reconstruction Market, Mexico, Company Share (%) 2014 68
Figure 27: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 70
Figure 28: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 72
Figure 29: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 74
Figure 30: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 76
Figure 31: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 78
Figure 32: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 80
Figure 33: Hip Reconstruction Market, United States, Volume (Units), Historic, 2007-2014 82
Figure 34: Hip Reconstruction Market, United States, Volume (Units), Forecast, 2014-2021 84
Figure 35: Partial Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014 86
Figure 36: Primary Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014 88
Figure 37: Partial Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021 90
Figure 38: Primary Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021 92
Figure 39: Hip Reconstruction Market, United States, Company Share (%) 2014 97
Figure 40: GlobalData Epidemiology-Based Forecasting Model 165
Figure 41: GlobalData Capital Equipment-Based Forecasting Model 166
Figure 42: Primary Interviews by Participant Type (%) 167

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Czech Republic Knee Reconstruction Market Outlook to 2022

Czech Republic Knee Reconstruction Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Czech Republic Knee Reconstruction Market Outlook to 2022 Summary GlobalData’s new report, Czech Republic Knee Reconstruction Market Outlook to 2022, provides key market data on the Czech Republic Knee ...

Saudi Arabia Shoulder Reconstruction and Small Joints Market Outlook to 2022

Saudi Arabia Shoulder Reconstruction and Small Joints Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Saudi Arabia Shoulder Reconstruction and Small Joints Market Outlook to 2022 Summary GlobalData’s new report, Saudi Arabia Shoulder Reconstruction and Small Joints Market Outlook to 2022, provides key ...

Taiwan Shoulder Reconstruction and Small Joints Market Outlook to 2022

Taiwan Shoulder Reconstruction and Small Joints Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Taiwan Shoulder Reconstruction and Small Joints Market Outlook to 2022 Summary GlobalData’s new report, Taiwan Shoulder Reconstruction and Small Joints Market Outlook to 2022, provides key market data ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.